Scarica l'app Stockscreener
11.59
1.70%
-0.20
Pre-mercato:
11.80
0.21
+1.81%
CorMedix Inc Borsa (CRMD) Ultime notizie
Despite shrinking by US$64m in the past week, CorMedix (NASDAQ:CRMD) shareholders are still up 366% over 3 years - simplywall.st
CorMedix stock rises after earnings, revenue beat - MSN
CorMedix stock soars to 52-week high, hits $15.33 By Investing.com - Investing.com South Africa
CorMedix stock soars to 52-week high, hits $15.33 - Investing.com Australia
Long Term Trading Analysis for (CRMD) - news.stocktradersdaily.com
Cormedix anticipates Q2 revenue at high end of $23M-$31M range with inpatient growth accelerating - MSN
CorMedix at Jefferies Healthcare: Strategic Expansion and Financial Growth By Investing.com - Investing.com Canada
CorMedix at Jefferies Healthcare: Strategic Expansion and Financial Growth - Investing.com Australia
CorMedix stock rises as Q1 earnings and revenue surpass estimates By Investing.com - Investing.com Nigeria
CorMedix: DefenCath In Exponential Growth Phase With Robust Market Position - Seeking Alpha
CorMedix:Exceeding Expectations (NASDAQ:CRMD) - Seeking Alpha
CorMedix Inc. to Present at Jefferies Global Healthcare Conference on June 5, 2025 - Nasdaq
CorMedix Inc. To Participate In The Jefferies Global Healthcare Conference - The Manila Times
CorMedix Brings Latest Therapeutic Developments to Jefferies Healthcare Conference 2025 - Stock Titan
(CRMD) Trading Advice - news.stocktradersdaily.com
CorMedix Inc. (CRMD) Stock Analysis: Unveiling a 37.30% Potential Upside in Healthcare Biotechnology - DirectorsTalk Interviews
CorMedix at RBC Capital Markets: Strategic Expansion and Growth - Investing.com Australia
CorMedix at RBC Capital Markets: Strategic Expansion and Growth By Investing.com - Investing.com India
CorMedix Inc. to Participate in the RBC Global Healthcare Conference - The Manila Times
CorMedix Inc. to Participate in RBC Capital Markets Global Healthcare Conference on May 21, 2025 - Nasdaq
Leading Biopharma CorMedix Set for Key Presentation at RBC Healthcare Conference Next Week - Stock Titan
CorMedix Inc. Makes NYSE MKT Section 610(b) Public Announcement - ACCESS Newswire
Surging Earnings Estimates Signal Upside for CorMedix (CRMD) Stock - Yahoo Finance
Market Highlights: CorMedix Inc (CRMD) Ends on a High Note at 12.03 - DWinneX
CorMedix Inc. Just Recorded A 22% EPS Beat: Here's What Analysts Are Forecasting Next - Yahoo Finance
CorMedix Inc. (CRMD): Among Billionaire Paul Singer’s Stock Picks with Huge Upside Potential - Insider Monkey
Cormedix (CRMD) Receives a Buy from RBC Capital - The Globe and Mail
CorMedix at Citizens JMP: Strategic Growth and Market Expansion By Investing.com - Investing.com Nigeria
CorMedix at Citizens JMP: Strategic Growth and Market Expansion - Investing.com
CorMedix Inc. (NASDAQ:CRMD) Q1 2025 Earnings Call Transcript - Insider Monkey
Analysts Just Shipped A Substantial Upgrade To Their CorMedix Inc. (NASDAQ:CRMD) Estimates - Yahoo Finance
CorMedix Inc. Reports Strong Q1 Earnings and Positive Outlook - MSN
CorMedix (CRMD) Surpasses Q1 Earnings and Revenue Estimates - MSN
(CRMD) Investment Analysis - news.stocktradersdaily.com
Earnings call transcript: CorMedix Q1 2025 results beat expectations, stock rises - Investing.com Nigeria
Cormedix Inc (CRMD) Q1 2025 Earnings Call Highlights: Record Profitability and Strategic Growth ... By GuruFocus - Investing.com Canada
CorMedix Inc. Reports Strong Q1 2025 Results - TipRanks
Earnings call transcript: CorMedix Q1 2025 results beat expectations, stock rises By Investing.com - Investing.com South Africa
CorMedix: Q1 Earnings Snapshot - Norwalk Hour
CorMedix Inc reports results for the quarter ended March 31Earnings Summary - TradingView
CRMD Price Target Increased as Positive Momentum Builds | CRMD S - GuruFocus
CorMedix Shares Soar After Q1 Earnings, Revenue Beat Consensus - MarketScreener
CorMedix Inc. to Report First Quarter 2025 Financial Results and Provide a Corporate Update on May 6, 2025 - The Globe and Mail
Cormedix Inc (CRMD) Q1 2025 Earnings: EPS of $0.32 Beats Estimat - GuruFocus
CorMedix (CRMD) Surpasses Revenue and EPS Expectations in Q1 - GuruFocus
CRMD Price Target Increased as Positive Momentum Builds | CRMD Stock News - GuruFocus
CorMedix Inc. Revises Sales Guidance for the First Half of 2025 - marketscreener.com
CorMedix (CRMD) Surges on Strong Q1 Earnings - GuruFocus
CorMedix Inc (NASDAQ: CRMD): Hidden Gems In A Time Of Volatility - Stocksregister
CRMD Stock Rating and Price Target Maintained by Analyst | CRMD - GuruFocus
1.45%
0.86%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):